Resistance-repellent retroviral protease inhibitors
US7109230B2 · kind B2 · utility
6Cited by
12References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2003 |
| Grant date | Sep 19, 2006 |
| Priority date | — |
| Expiry date | Aug 18, 2023 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Resistance-repellent and multidrug resistant retroviral protease inhibitors are provided. Pharmaceutical composition comprising such compounds, and methods of using such compounds to treat HIV infections in mammals, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.